{
"id":"mk19_b_en_q046",
"number":46,
"bookId":"en",
"correctAnswer":"B",
"title":"Question 46",
"stimulus":[
{
"type":"p",
"hlId":"5a1cb7",
"children":[
"A 70-year-old woman is evaluated for incidentally discovered hypercalcemia. She has no symptoms or other medical conditions and takes no medications."
]
},
{
"type":"p",
"hlId":"a84326",
"children":[
"On physical examination, vital signs are normal. A height loss of 5 cm (2.0 inches) has occurred since age 65 years. Thoracic kyphosis is noted."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"1a4da4",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Calcium, serum",
"children":[
"Calcium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e41e7c",
"class":"cell text l",
"children":[
"10.8 mg/dL (2.7 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e8394c",
"class":"cell text l",
"children":[
"0.8 mg/dL (70.7 Î¼mol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"a4922e",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Phosphorus, serum",
"children":[
"Phosphorus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e3b5b2",
"class":"cell text l",
"children":[
"2.5 mg/dL (0.81 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"ca2815",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Parathyroid hormone, serum",
"children":[
"Parathyroid hormone"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"2ea07d",
"class":"cell text l",
"children":[
"77 pg/mL (77 ng/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"743b71",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Vitamin D",
"children":[
"25-Hydroxyvitamin D"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"9ce180",
"class":"cell text l",
"children":[
"30 ng/mL (75.0 nmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"9fe2e8",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Calcium, urine",
"children":[
"24-Hour urine calcium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"fa1c56",
"class":"cell text l",
"children":[
"260 mg/24 h"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"986699",
"children":[
"Kidney-urinary-bladder radiograph is negative for kidney stones. Dual-energy x-ray absorptiometry scan shows femur neck T-score of -1.9, lumbar spine T-score -1.8, and distal one-third radius T-score of -1.7."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"cb2b54",
"children":[
"Which of the following is the most appropriate management?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Order parathyroid sestamibi scan"
}
},
{
"letter":"B",
"text":{
"__html":"Order thoracic and lumbar spine radiography"
}
},
{
"letter":"C",
"text":{
"__html":"Repeat serum calcium and creatinine measurement in 6 months"
}
},
{
"letter":"D",
"text":{
"__html":"Start alendronate"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"d546d3",
"children":[
"In patients with primary hyperparathyroidism, bone-related indications for parathyroidectomy include fragility fractures, vertebral fractures, and a dual-energy x-ray absorptiometry T-score of less than -2.5 or less at lumbar spine, total hip, femoral neck, or distal one-third radius."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"250b55",
"children":[
"The most appropriate management for this patient is thoracic and lumbar spine radiography (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). This patient has hypercalcemia, hypophosphatemia, and an inappropriately elevated serum parathyroid hormone level, establishing the diagnosis of primary hyperparathyroidism. For asymptomatic patients with primary hyperparathyroidism, additional evaluation is necessary to determine if parathyroidectomy is indicated. Evaluation in most patients includes assessment of kidney function, bone mineral density (BMD) measurement, and in some patients, assessment for nephrolithiasis or nephrocalcinosis. In addition to evidence of bone disease, indications for parathyroidectomy in patients with primary hyperparathyroidism include age younger than 50 years; serum calcium 1 mg/dL (0.3 mmol/L) or greater above upper limit of normal; creatinine clearance less than 60 mL/min; 24-hour urine calcium greater than 400 mg/dL (100 mmol/L); or nephrolithiasis or increased risk for kidney stones. This patient's evaluation is nearly complete except for evaluation for vertebral fractures. Because this patient's height loss and kyphosis suggest the possibility of vertebral fractures, she should undergo thoracic and lumbar spine radiography; the presence of vertebral fractures would be an indication for parathyroidectomy."
]
},
{
"type":"p",
"hlId":"01b1cb",
"children":[
"A parathyroid sestamibi scan (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") or neck ultrasonography may be appropriate for preoperative adenoma localization if surgery is indicated. Localization studies, however, do not influence the choice between surgical and medical management of primary hyperparathyroidism."
]
},
{
"type":"p",
"hlId":"4dd674",
"children":[
"Patients without indications for parathyroidectomy require periodic reassessment that includes repeat serum calcium and creatinine measurement (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") every 6 to 12 months and BMD measurement of the lumbar spine, hip, and distal radius every 2 years. This patient requires further assessment for the presence of vertebral fractures before deciding on a monitoring strategy versus parathyroidectomy."
]
},
{
"type":"p",
"hlId":"c440da",
"children":[
"Although alendronate (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") suppresses bone resorption and improves BMD at the lumbar spine in patients with primary hyperparathyroidism, it has not been shown to reduce fracture risk, serum calcium levels, or urine calcium levels in these patients. Patients at high risk for fracture (T-score <-2.5 at lumbar spine, total hip, femoral neck, or distal one-third radius and/or prevalent fragility fracture) at presentation or during monitoring should undergo parathyroidectomy. Alendronate would be an appropriate option for a patient with primary hyperparathyroidism and concurrent osteoporosis who was unable or unwilling to undergo surgery."
]
}
],
"relatedSection":"mk19_b_en_s7_2_2_2_1",
"objective":{
"__html":"Manage asymptomatic primary hyperparathyroidism."
},
"references":[
[
"Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018;379:1050-1059. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30207907",
"target":"_blank"
},
"children":[
"PMID: 30207907"
]
},
" doi:10.1056/NEJMcp1714213"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":42,
"B":11,
"C":29,
"D":19,
"E":0
},
"hlIds":[
"5a1cb7",
"a84326",
"a462a3",
"1a4da4",
"e41e7c",
"f461b2",
"e8394c",
"a4922e",
"e3b5b2",
"ca2815",
"2ea07d",
"743b71",
"9ce180",
"9fe2e8",
"fa1c56",
"986699",
"cb2b54",
"d546d3",
"250b55",
"01b1cb",
"4dd674",
"c440da"
]
}